LEGAL PROCEEDINGS - Intellectual Property (Details)						1 Months Ended				3 Months Ended
	May 02, 2024 proceeding	Feb. 28, 2024	Jul. 21, 2022	Sep. 10, 2021	Mar. 26, 2020	Oct. 31, 2023	Jan. 31, 2023	Apr. 30, 2021	Mar. 31, 2021 proceeding defendant	Mar. 31, 2024 proceeding
Norwich Pharmaceuticals Inc. Litigation
Loss Contingencies [Line Items]
Stay of approval, period		30 months			30 months	30 months	30 months
Taro Pharmaceuticals Inc. Litigation
Loss Contingencies [Line Items]
Stay of approval, period			30 months
MSN Laboratories Private Ltd. Litigation
Loss Contingencies [Line Items]
Stay of approval, period								30 months
PreserVision® AREDS Patent Litigation | Settled Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants										13
PreserVision® AREDS Patent Litigation | Default Judgement | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants										2
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants | defendant									19
Number of proceedings									16
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb | Subsequent Event
Loss Contingencies [Line Items]
Number of defendants	1
Lumify Paragraph I V Proceedings Slayback ANDA Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Stay of approval, period				30 months